A Feasibility Pilot Comparing a Non-invasive Low Level Laser Therapy (LLLT) With Lorcaserin to Reduce Central Adiposity in Overweight Individuals.
Phase of Trial: Phase III
Latest Information Update: 24 Nov 2016
Price : $35 *
At a glance
- Drugs Lorcaserin (Primary)
- Indications Obesity; Overweight
- Focus Therapeutic Use
- 05 Jan 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 14 Aug 2015 Planned End Date changed from 1 Sep 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov.
- 14 Aug 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.